Ogiso, H., Miura, K., Nagai, R., Osaka, H., & Aizawa, K. Non-Targeted Metabolomics Reveal Apomorphine’s Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis. MDPI AG.
Chicago Style (17th ed.) CitationOgiso, Hideo, Kouichi Miura, Ryozo Nagai, Hitoshi Osaka, and Kenichi Aizawa. Non-Targeted Metabolomics Reveal Apomorphine’s Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis. MDPI AG.
MLA (9th ed.) CitationOgiso, Hideo, et al. Non-Targeted Metabolomics Reveal Apomorphine’s Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis. MDPI AG.
Warning: These citations may not always be 100% accurate.